Recent news on Tirofiban Hydrochloride

MGI PHARMA Reports Fourth Quarter and Full Year 2006 Financial Results  -  Feb 8, 2007
PharmaLive.com (press release),...acquired in process research and development expenses, transactions costs related to the divestiture of Aggrastat(R) (tirofiban hydrochloride) Injection

Medicure Completes US$25.9 Million Private Placement  -  Dec 28, 2006
Genetic Engineering News (press release),The Company acquired the exclusive US rights to AGGRASTAT(R) Injection (tirofiban hydrochloride) from MGI PHARMA, INC for US$19 million.

MGI PHARMA Reports Third Quarter 2006 Financial Results  Oct 18, 2006
...$1.0 million of amortization of product acquisition intangible assets, $0.5 million of Aggrastat® injection (tirofiban hydrochloride) transaction-related ... -Business Wire (press release), Medicure Announces Financial Results for Fiscal First Quarter 2007  Oct 12, 2006
The Company announced that acquisition of the exclusive US rights to AGGRASTAT Injection (tirofiban hydrochloride) from MGI PHARMA, INC. ... -PharmaLive.com (press release), Medicure Announces Launch of US Sales Organization  Oct 11, 2006
...company, today announced the launch of its US sales organization to support the sales and marketing efforts for AGGRASTAT® injection (tirofiban hydrochloride ... -Market Wire (press release) Medicure Reports Highlights and Financial Results for Fiscal 2006  Aug 15, 2006
Subsequent to fiscal 2006, the Company acquired the US rights to its first commercial product, AGGRASTAT ® Injection (tirofiban hydrochloride) in the US for ... -CCNMatthews

Medicure Acquires Marketed CV Drug Aggrastat From MGI  Aug 9, 2006
Launched in the US in 1998, Aggrastat (tirofiban hydrochloride) has had modest sales because it has lacked a sustained sales support the past several years. ... -BioWorld Online

Medicure Acquires US Rights to Aggrastat'R' from MGI PHARMA, INC.  Aug 9, 2006
...biopharmaceutical company, today announced that the Company has acquired the exclusive US rights to AGGRASTAT® Injection (tirofiban hydrochloride) from MGI ... -Market Wire

Medicure Acquires US Rights To Aggrastat From MGI Pharma  Aug 9, 2006
Medicure Inc. (MCU) has acquired the exclusive US rights to AGGRASTAT Injection (tirofiban hydrochloride) from MGI Pharma Inc. (MOGN). ... -Easy Bourse (Communiqués de presse)

MGI PHARMA Reports Second Quarter 2006 Financial Results  Jul 19, 2006
Injection, the inclusion of sales of Gliadel(R) Wafer (polifeprosan 20 with carmustine implant) and Aggrastat(R) (tirofiban hydrochloride) Injection following ... -Business Wire

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional